| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/01/2006 | CN1243565C Traditional Chinese medicine pain-relieving bag |
| 03/01/2006 | CN1243556C Medicinal wine for treating rheumatism arthritis |
| 03/01/2006 | CN1243552C Functional medical wine for treating various diseases |
| 03/01/2006 | CN1243549C Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method |
| 03/01/2006 | CN1243538C Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method |
| 03/01/2006 | CA2479968A1 Protein c and endothelial protein c receptor polymorphisms as indicators of patient outcome |
| 02/28/2006 | US7005516 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005509 Pancreatic expressed chemokines, (PANEC-1); expression vectors, host cells, and diagnostic tests using probes for physiologic or pathologic compromise of the pancreas |
| 02/28/2006 | US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005422 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005279 Process for producing carbohydrates using β 1,3-N-acetyl-glucosaminyltransferase |
| 02/28/2006 | US7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 02/28/2006 | US7005121 Arerosol; heating drug, vaporization, cooling |
| 02/28/2006 | CA2332535C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/24/2006 | CA2533320A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2006 | WO2006020979A2 Factor vii conjugates for selectively treating neovascularization disorders |
| 02/23/2006 | WO2006018727A2 Triazolopyridine compounds useful for the treatment of inflammation |
| 02/23/2006 | WO2006018718A2 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 02/23/2006 | WO2006018698A2 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 02/23/2006 | WO2006017994A1 An analgesic pharmaceutical composition |
| 02/23/2006 | WO2005061538A3 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 02/23/2006 | WO2004067018A8 Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041130 Syntheses of quinazolinones |
| 02/23/2006 | US20060041124 Process for preparing pyrrolotriazine kinase inhibitors |
| 02/23/2006 | US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 02/23/2006 | US20060040988 antiinflammatory, antipyretic and analgesic agents; side effects redution; N-(cyclohexylmethyl)-6-[4-(methylsulfonyl)phenyl]-4-(trifluoromethyl)-2-pyridinamine; osteoarthritis; rheumatoid arthritis |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040972 Pyrazolonaphthyridine derivative |
| 02/23/2006 | US20060040967 6-Fluoroalkyl-4-(5-sulfonyl-2-pyridyl)-substituted, e.g., 4-(5-Methanesulfonyl-pyridin-2-yl)-6-trifluoromethyl-pyrimidin-2-yl]-methyl-(6-methyl-pyridin-2-ylmethyl)-amine; treating pain, fever and inflammation without the potential side effects of other COX inhibitors |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040959 Adenosine A3 receptor modulators |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040947 inflammation; N-(4-Phenylpyridin-2-yl)isoquinolin-5-amine; analgesis; antinociceptive agents |
| 02/23/2006 | US20060040942 Antiinflammatory agents; autoimmune disease |
| 02/23/2006 | US20060040941 7-Aminoimidazotriazones |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040907 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040869 Pharmaceutically useful compounds |
| 02/23/2006 | US20060040853 Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 02/23/2006 | US20060040851 Gag-peptide complex |
| 02/23/2006 | US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | US20060039953 Water soluble polymer such as pullulan and an antimicrobial effective amount of thymol, methyl salicylate, eucalyptol and/or menthol; killing the plaque-producing germs that cause dental plaque, gingivitis and bad breath |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039917 Method for treating phantom pain by peripheral administration of a neurotoxin |
| 02/23/2006 | US20060039916 Method for treating complex regional pain by peripheral administration of a neurotoxin |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004039382A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives |
| 02/23/2006 | CA2589971A1 Method of treating trauma or sepsis |
| 02/23/2006 | CA2577698A1 Infant formula |
| 02/23/2006 | CA2577648A1 Triazolopyridine compounds useful for the treatment of inflammation |
| 02/23/2006 | CA2577274A1 Anti-inflammatory agents |
| 02/23/2006 | CA2576291A1 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 02/23/2006 | CA2576274A1 Para-alkyl-substituted n-(4-hydroxy-3-methoxybenzyl)-cinnamic acid amides and the use thereof for the preparation of medicinal drugs |
| 02/23/2006 | CA2576042A1 Immune stimulatory infant nutrition |
| 02/23/2006 | CA2573764A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 02/23/2006 | CA2573730A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 02/23/2006 | CA2573720A1 Netrin-related compositions and uses |
| 02/22/2006 | EP1627883A1 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A derivatives |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627873A1 Benzofuran compound and medicinal composition containing the same |
| 02/22/2006 | EP1627870A1 Cyanofluoropyrrolidine derivative |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1627866A1 Carboxylic acid compound and medicine containing the same |
| 02/22/2006 | EP1627644A1 PREPARTAION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1a PRODUC TION INHIBITOR |
| 02/22/2006 | EP1627640A1 Sulfate group transferase inhibitor |
| 02/22/2006 | EP1627633A1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 02/22/2006 | EP1626973A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo 3.2.0]heptane is an effective analgesic agent |
| 02/22/2006 | EP1626964A2 New benzimidazole derivatives |
| 02/22/2006 | EP1626736A1 C1 inhibitor with short half-life for transient treatment |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | EP1194584B1 Method for producing oligopolysaccharides |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0814837B2 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 02/22/2006 | CN1738812A Thiophene carboxamides as inhibitors of the enzyme IKK-2 |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738796A Bis-aryl sulfonamides |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738632A Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1738612A Drinkable preparation comprising ketoprofen and the use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 02/22/2006 | CN1738609A Adhesive composition for dermal patch and production process thereof |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1737103A Propolis wine |
| 02/22/2006 | CN1737101A Ledebouriella root health care wine |